My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ:IRON)

65.86 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 65.86
Bid (Size) 26.35 (2)
Ask (Size) 104.71 (1)
Prev. Close 65.86
Today's Range 65.86 - 65.86
52wk Range 30.82 - 68.79
Shares Outstanding 22,877,552
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire

Performance

YTD
+5.5%
+5.5%
1 Month
+7.3%
+7.3%
3 Month
+20.3%
+20.3%
6 Month
+43.9%
+43.9%
1 Year
+28.6%
+28.6%

More News

Read More
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
From Shattuck Labs, Inc.
Via GlobeNewswire
Disc Medicine (IRON) Q2 Loss Widens 109%
Via The Motley Fool
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)
From Disc Medicine Inc
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?
Yes, Disc Medicine, Inc. - Common Stock is publicly traded.
What exchange does Disc Medicine, Inc. - Common Stock trade on?
Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Disc Medicine, Inc. - Common Stock?
The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market
What is the current price of Disc Medicine, Inc. - Common Stock?
The current price of Disc Medicine, Inc. - Common Stock is 65.86
When was Disc Medicine, Inc. - Common Stock last traded?
The last trade of Disc Medicine, Inc. - Common Stock was at 10/02/25 04:00 PM ET
What is the market capitalization of Disc Medicine, Inc. - Common Stock?
The market capitalization of Disc Medicine, Inc. - Common Stock is 1.51B
How many shares of Disc Medicine, Inc. - Common Stock are outstanding?
Disc Medicine, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.